| Literature DB >> 34721719 |
Dheeratama Siripongsatian1, Chetsadaporn Promteangtrong1, Anchisa Kunawudhi1, Peerapon Kiatkittikul1, Chanisa Chotipanich1.
Abstract
A patient with intrahepatic cholangiocarcinoma who underwent hepatic resection with completed neoadjuvant chemotherapy presented with increased CEA levels. Previous whole abdominal and chest CT scan revealed no evidence of local recurrence or metastasis. 68 Ga-FAPI-46 PET showed significantly higher tumor-to-background contrast of recurrent tumor and nodal metastasis, which were undetectable in the FDG PET or conventional CT scan. These findings changed patient management. Larger studies with histopathological correlation and comparisons with other imaging modalities are required to validate the diagnostic performance. Moreover, a cystic lesion with FAPI uptake at the neck to the proximal body of the pancreas without FDG uptake is also incidentally noted. Differential diagnoses include sided branch IPMN and serous cystadenoma. © Korean Society of Nuclear Medicine 2021.Entities:
Keywords: Cholangiocarcinoma; FDG; Fibroblast activation protein; Intraductal papillary mucinous neoplasm (IPMN); PET/CT; PET/MRI
Year: 2021 PMID: 34721719 PMCID: PMC8517048 DOI: 10.1007/s13139-021-00712-8
Source DB: PubMed Journal: Nucl Med Mol Imaging ISSN: 1869-3474